Market closed·Syncing…
SMEMarket closed · Close · 19 Nov

Biopol Chemicals Limited BIOPOLshare price and chart

Biopol Chemicals closed at ₹45.15 on 19 November 2026, up 5.00% on the day. The range since listing is ₹39.50 to ₹133.75.

₹45.15The price one share last traded at, in rupees.+5.00% · ₹2.15
Low since listing ₹406% up the rangeThe highest and lowest price the share has traded at in the past year, and where today's price sits between the two.high ₹134

Daily candlesEach candle is one trading day. The chart opens on the last year; drag back past the start or open full screen and the rest loads, back to listing (or the first day in our data). The body runs from the open to the close, the thin lines to the high and low. Green closed up, red closed down.

Loading prices…

Split and bonus adjusted daily candles. Drag back past the start, or open full screen, and its whole history loads. Scroll or pinch to zoom; full screen adds indicators, drawing and measuring.

Test a strategy on BIOPOL

Real prices, every charge counted. Pick one or write your own.
What Biopol Chemicals Limited does
A short, human-reviewed summary of the business, written from public sources. Background, not analysis, and not updated intraday.
business summary

Biopol Chemicals makes 66 speciality chemicals in four groups: silicones, emulsifiers, biochemicals and polyelectrolytes. They are used in textile softeners and finishes, home care cleaning chemicals, agricultural adjuvants and industrial release agents, and it also offers technical consultancy.

1
1Sector

Chemicals & Petrochemicals

2
2What it sells

Silicones, emulsifiers, biochemicals, polyelectrolytes

3
3Who buys it

Textile, home care, agriculture and industrial chemical companies

Technical snapshotHow the share has been behaving: its momentum, its trend, how much of the trading was real buying to keep, and its returns.

EOD 19 Nov
RSI (14) · 30 oversold, 70 overboughtA score from 0 to 100 showing how strong recent up days were against recent down days.
45.8Neutral
0 oversold3070overbought 100
Delivery · bought to hold vs churnOf all the shares traded in a day, the share that actually changed hands and went into someone's demat account, rather than being bought and sold the same day.
33.3%Below average - weaker conviction
today 33.3%20d avg 88.4%

The share of traded quantity that was actually delivered (not squared off intraday) - high delivery vs its 20-session average suggests real buying or holding, not just churn.

vs 50 DMAHow far today's close is above or below the average closing price of the last 50 trading days. It shows the medium-term trend.▼ 3.8%1 monthHow much the share price has changed over the period.▼ 0.4%3 monthsHow much the share price has changed over the period.▼ 50.1%Vol 30dHow much the share has actually been moving day to day, stated as a yearly percentage. 30% means it swung roughly 30% a year at that pace.57.3%

Returns and valuationWhat the market pays for this company and how well the business uses its money.

Books to 30 Sept 2026
Market capWhat the whole company is worth on the stock market: share price times the number of shares. It measures size, not quality.₹49 Cr19 NovP/EHow many rupees investors pay today for one rupee of the company's yearly profit. A P/E of 20 means paying ₹20 for ₹1 of annual profit.4.1xlast 4 quarters, to Sept 2026Price to bookThe share price against the shareholders' money per share on the balance sheet. It asks what you pay for each rupee the owners have in the business.0.88xbooks of Sept 2026Return on capitalHow much operating profit the company made on all the money in the business, whether it came from owners or lenders.23.3%full year FY26Dividend yieldThe cash paid out in a year as a percentage of today's share price. A 2% yield means ₹2 a year on a ₹100 share.0.00%last 12 monthsDebt to equityBorrowings compared with the shareholders' money. 1 means the company owes as much as its owners have put in; 0 means no borrowings.0.33xbooks of Sept 2026FCF marginOf every ₹100 of sales, how much cash was left after running the business and paying for new assets.-33.1%year to Mar 2026

Against its sectorWhere this company ranks among similar companies on each measure.

Specialty Chemicals · 90 peers · medians
P/EHow many rupees investors pay today for one rupee of the company's yearly profit. A P/E of 20 means paying ₹20 for ₹1 of annual profit.4.07vs 25.31 median
Cheapest: BIOPOL 4.07Priciest: INDOKEM 785.75
Net marginOf every ₹100 of sales, how much is left as profit after all costs, interest and tax.12%vs 7.21% median
Lowest: DIAMINESQ -19.71%Highest: SUDEEPPHRM 26.58%

Shareholding patternThe share of the company held by its promoters, by foreign and domestic institutions, and by the public, quarter by quarter.

Who owns it
65.81%promoter holding, as of 2026-09-30+0.0 pts since 2026
Promoter share since listing
2026-0265.81% now, drawn to its own range2026-09
Who owns it todayas of Sep 26
65.8%
33.7%
Promoter65.8%Foreign (FII)0.5%Public & others33.7%
Who is buying, who is leavingFeb 26 to Sep 26
Promoter65.8%steady
Foreign (FII)0.5%-8.8 pts
Domestic (DII)0.5%-5.8 pts

Each line is that holder's share of all shares over the last 4 quarters, drawn to its own scale - the printed change is the size of the move. Mutual funds and insurers sit inside the domestic figure; hover the bar above for that split.

The promoter/promoter-group stake as a percentage of total shares, each quarter since listing. A rising line means promoters are adding to their stake; a falling one often means dilution, pledge-driven sales, or stake sales to new investors.

Recent announcementsThe company's own filings to the exchange in the last six months: results, board meetings, investor calls and more, each with its source document.

Last 6 months
Statement of deviation(s) or variation(s) under Reg. 3205-Nov-2026

Biopol Chemicals Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32

Outcome of Board Meeting05-Nov-2026

Outcome of Meeting of Board of Directors held today i.e. Thursday, November 05, 2026 for Consideration and approval of Unaudited Standalone Financial Results for the Half Year ended on September 30, 2026

Quarterly Compliance Report on Corporate governance - within 21 days from the end of the quarter10-Oct-2026

Non-Applicability of Corporate Governance Report under Regulation 27(2) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the Quarter and Half Year ended September 30, 2026.

Certificate under SEBI (Depositories and Participants) Regulations, 201810-Oct-2026

Submission of Certificate under Regulation 74(5) of SEBI (Depositories and Participants)Regulations, 2018, for the quarter and half year ended September 30, 2026.

Trading Window28-Sep-2026

Biopol Chemicals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

Shareholders meeting24-Sep-2026

Voting Results in respect of the 03rd Annual General Meeting of the Company along with the Scrutinizer's Report.

General Updates22-Sep-2026

Biopol Chemicals Limited has informed the Exchange about Regularisation of appointment of Mr. Sukhomoy Das (DIN: 11761165) as an Independent Director of the Company for a first term of five consecutive years

Shareholders meeting22-Sep-2026

Biopol Chemicals Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 22, 2026 at 02:00 P.M. IST, through video conferencing and other audio-visual means via ZOOM Platform.

Updates05-Sep-2026

Biopol Chemicals Limited has informed the Exchange regarding 'Participation in 53rd Dye+Chem Bangladesh 2026 INT L Expo'.

General Updates31-Aug-2026

Biopol Chemicals Limited has informed the Exchange about General Updates i.e. Clarification with respect to significant movement in price of our Company''s security.

Price movement28-Aug-2026

Significant movement in price has been observed in Biopol Chemicals Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited.

Copy of Newspaper Publication27-Aug-2026

Biopol Chemicals Limited has informed the Exchange about Copy of Newspaper Publication

General Updates26-Aug-2026

Biopol Chemicals Limited has informed the Exchange about Dispatch Of Letter With Web-Link Of Annual Report For Financial Year 2025-26 to the Shareholders whose e-mail addresses are not registered with the Company

Shareholders meeting26-Aug-2026

Biopol Chemicals Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 22, 2026 at 02:00 P.M. IST through Video Conferencing ( VC )/ Other Audio Visual Means ( OAVM )

Outcome of Board Meeting25-Aug-2026

Biopol Chemicals Limited has informed the Exchange regarding Outcome of Board Meeting held on August 25, 2026.

Backtest idea · BIOPOLMACD momentum

Momentum turning up, only while the long trend is up.

BuyMACD crosses above signal, price above 200-day SMA
SellMACD crosses back below
Real prices · every charge countedRun on BIOPOL
Backtest idea · BIOPOLLower band bounce

Buys a stretch below the usual range, sells on the way back.

BuyCloses below the lower Bollinger band
SellBack at the middle band, or 15 days
Real prices · every charge countedRun on BIOPOL
Backtest idea · BIOPOLSupertrend rider

Stays in while the trend line says up, out when it flips.

BuySupertrend turns up
SellSupertrend turns down
Real prices · every charge countedRun on BIOPOL
Your own ideaWrite a rule for BIOPOL in plain English“Buy BIOPOL when …”
Start writing
Buy the dip on BIOPOLBuy when RSI(14) drops below 30
52-week high breakout on BIOPOLBuy when closes at a 52-week high
Golden cross on BIOPOLBuy when 50-day EMA crosses above 200-day
Stochastic oversold on BIOPOLBuy when stochastic %K drops below 20
Pullback in an uptrend on BIOPOLBuy when RSI(14) below 40, price above 200-day EMA

Key ratios at a glanceThe eight figures most people check first, each placed against companies in the same industry.

Against its sector
Market capWhat the whole company is worth on the stock market: share price times the number of shares. It measures size, not quality.
₹49 cr
Larger than 6% of 90 peers
sector middle ₹1,223 cr
P/EHow many rupees investors pay today for one rupee of the company's yearly profit. A P/E of 20 means paying ₹20 for ₹1 of annual profit.
4.1x
Lowest of 79 peers
sector middle 25.3x
Price to bookThe share price against the shareholders' money per share on the balance sheet. It asks what you pay for each rupee the owners have in the business.
0.9x
Lower than 89% of 80 peers
sector middle 2.6x
ROCEHow much operating profit the company made on all the money in the business, whether it came from owners or lenders.
23.3%
Higher than 92% of 78 peers
sector middle 11.4%
Debt to equityBorrowings compared with the shareholders' money. 1 means the company owes as much as its owners have put in; 0 means no borrowings.
0.33
Higher than 62% of 79 peers
sector middle 0.25
Dividend yieldThe cash paid out in a year as a percentage of today's share price. A 2% yield means ₹2 a year on a ₹100 share.
0.0%
Lower than 63% of 90 peers
sector middle 0.2%

Peers are the listed companies in the exchange's own industry group: Specialty Chemicals. Balance-sheet figures are from the latest filed balance sheet; trends show each financial year we hold.

Cash flowProfit is an accounting figure. Cash flow shows the money that really moved: in from the business, out on investments, and to or from lenders and shareholders.

Where the cash went

In FY26 cash fell by ₹1 Cr, after ₹14 Cr spent on plant and equipment.

FY26Cash in or out
Running the business-₹13 Cr
Investing-₹15 Cr
Lenders and shareholders+₹27 Cr
Net change in cash-₹1 Cr

The full numbersSales and net profit by financial year or by quarter.

Backtest idea · BIOPOLStochastic oversold

Buys when the close sits near the bottom of its recent range.

BuyStochastic %K drops below 20
Sell8% profit, or after 15 days
Real prices · every charge countedRun on BIOPOL
Backtest idea · BIOPOLPullback in an uptrend

Buys a pause inside a rising trend.

BuyRSI(14) below 40, price above 200-day EMA
Sell8% profit, or after 30 days
Real prices · every charge countedRun on BIOPOL
Backtest idea · BIOPOLBuy the dip

Buys after a sharp fall, betting on a bounce.

BuyRSI(14) drops below 30
Sell10% profit, or after 20 days
Real prices · every charge countedRun on BIOPOL
Backtest idea · BIOPOL52-week high breakout

Buys strength, when the price makes a new one-year high.

BuyCloses at a 52-week high
Sell8% stop loss
Real prices · every charge countedRun on BIOPOL
Backtest idea · BIOPOLGolden cross

Follows the long trend: in when the fast average crosses above the slow one.

Buy50-day EMA crosses above 200-day
SellWhen it crosses back below
Real prices · every charge countedRun on BIOPOL
MACD momentum on BIOPOLBuy when MACD crosses above signal, price above 200-day SMA
Lower band bounce on BIOPOLBuy when closes below the lower Bollinger band
Supertrend rider on BIOPOLBuy when supertrend turns up
Buy the dip on BIOPOLBuy when RSI(14) drops below 30
52-week high breakout on BIOPOLBuy when closes at a 52-week high

Peers side by sideCompanies in the same exchange-defined industry group, largest first. Tap a heading to sort.

Specialty Chemicals
CompanyWhat the whole company is worth on the stock market: share price times the number of shares. It measures size, not quality.How many rupees investors pay today for one rupee of the company's yearly profit. A P/E of 20 means paying ₹20 for ₹1 of annual profit.The share price against the shareholders' money per share on the balance sheet. It asks what you pay for each rupee the owners have in the business.How much profit the company made on the shareholders' money in the business. 15% means ₹15 of profit a year on every ₹100 of owners' money.How much operating profit the company made on all the money in the business, whether it came from owners or lenders.Borrowings compared with the shareholders' money. 1 means the company owes as much as its owners have put in; 0 means no borrowings.Of every ₹100 of sales, how much is left as profit after all costs, interest and tax.How much sales grew in the latest quarter against the same quarter a year earlier.The cash paid out in a year as a percentage of today's share price. A 2% yield means ₹2 a year on a ₹100 share.
PIDILITIND
Pidilite Industries Limited
1.61 L cr59.9x14.3x23.5%31.8%0.0016.8%+20.9%0.73%
SRF
SRF Limited
74,518 cr32.6x4.9x13.8%14.2%0.3412.5%+34.7%0.40%
FLUOROCHEM
Gujarat Fluorochemicals Limited
54,690 cr81.0x6.5x7.5%9.8%0.2611.4%+45.5%0.06%
NAVINFLUOR
Navin Fluorine International Limited
52,334 cr57.5x11.7x20.1%21.4%0.2722.4%+57.0%0.16%
AETHER
Aether Industries Limited
22,517 cr90.1x8.7x9.8%11.6%0.2519.2%+26.2%0.00%
DEEPAKNTR
Deepak Nitrite Limited
21,172 cr19.9x3.3x9.8%11.5%0.2510.9%+61.8%0.48%
FINEORG
Fine Organic Industries Limited
16,731 cr34.7x5.7x16.8%22.0%0.0518.5%+22.1%0.20%
AARTIIND
Aarti Industries Limited
16,565 cr27.9x2.6x7.3%7.0%0.825.6%+74.7%0.22%
ANURAS
Anupam Rasayan India Limited
15,108 cr83.8x3.0x5.8%7.4%0.348.9%+10.2%0.11%
ATUL
Atul Limited
14,909 cr19.3x2.3x11.5%14.9%0.0211.3%+20.9%0.59%
PRIVISCL
Privi Speciality Chemicals Limited
13,809 cr37.0x8.8x24.8%22.2%0.6113.4%+12.0%0.42%
SUDEEPPHRM
Sudeep Pharma Limited
13,691 cr71.9x14.3x19.4%22.5%0.1926.6%+20.9%0.12%
BASF
BASF India Limited
12,561 cr21.0x2.9x11.1%15.2%0.003.5%+19.4%0.86%
VINATIORGA
Vinati Organics Limited
12,162 cr29.5x3.7x14.9%19.8%0.0016.4%+23.6%0.72%
ELANTAS
Elantas Beck India Limited
9,554 cr51.1x----18.9%+22.5%0.06%
JUBLINGREA
Jubilant Ingrevia Limited
9,138 cr25.8x2.8x9.2%11.0%0.277.1%+24.4%0.87%
NEOGEN
Neogen Chemicals Limited
8,678 cr192.9x5.5x3.6%6.6%0.994.0%+41.8%0.03%
ALKYLAMINE
Alkyl Amines Chemicals Limited
8,045 cr32.5x4.9x12.3%16.6%0.0114.1%+26.1%0.64%
GALAXYSURF
Galaxy Surfactants Limited
7,777 cr19.1x2.6x10.5%13.4%0.086.5%+36.5%1.82%
CLEAN
Clean Science and Technology Limited
7,407 cr31.8x4.4x15.3%20.7%0.0022.5%+22.4%0.86%
BALAMINES
Balaji Amines Limited
6,086 cr25.6x2.9x8.1%11.0%0.0714.6%+37.3%0.59%
ACI
Archean Chemical Industries Limited
5,395 cr53.8x2.8x5.5%7.8%0.288.3%+27.5%0.57%
FCL
Fineotex Chemical Limited
5,245 cr31.5x5.4x14.9%18.3%0.0113.2%+181.5%0.11%
PRASOLCHEM
Prasol Chemicals Limited
4,597 cr-7.5x--0.11--0.00%
FOSECOIND
Foseco India Limited
4,490 cr38.0x4.2x10.2%14.5%0.0014.4%+67.3%0.42%
YASHO
Yasho Industries Limited
4,361 cr50.4x8.5x5.8%9.1%1.207.8%+89.7%0.01%
LXCHEM
Laxmi Organic Industries Limited
4,280 cr24.9x2.0x4.1%4.7%0.344.9%+54.7%0.19%
EPIGRAL
Epigral Limited
4,077 cr14.3x1.7x16.1%15.7%0.2410.2%+27.0%0.53%
CHEMPLASTS
Chemplast Sanmar Limited
3,953 cr-2.5x-14.6%-3.6%1.11-7.6%+28.1%0.00%
TATVA
Tatva Chintan Pharma Chem Limited
3,830 cr60.9x4.7x5.5%7.1%0.219.7%+75.9%0.12%
VISHNU
Vishnu Chemicals Limited
3,725 cr24.4x3.3x14.2%16.3%0.628.8%+7.1%0.05%
STYRENIX
Styrenix Performance Materials Limited
3,252 cr12.9x2.2x14.4%15.9%0.166.8%+24.4%2.49%
JUBLCPL
Jubilant Agri and Consumer Products Limited
2,736 cr26.1x5.2x32.6%41.1%0.335.1%+15.0%0.00%
DDEVPLSTIK
Ddev Plastiks Industries Limited
2,528 cr11.6x2.3x21.8%31.1%0.066.3%+43.8%0.72%
ROSSARI
Rossari Biotech Limited
2,371 cr15.5x1.7x11.8%14.7%0.265.7%+19.0%0.12%
NOCIL
NOCIL Limited
2,318 cr29.7x1.3x3.1%4.4%0.005.3%+33.2%1.08%
SHK
S H Kelkar and Company Limited
1,758 cr18.6x1.2x5.3%7.9%0.683.7%+14.9%0.79%
INDOKEM
Indokem Limited
1,753 cr785.8x----1.2%+17.3%0.00%
NITTAGELA
Nitta Gelatin India Limited
1,584 cr15.3x----17.5%+1.5%0.40%
BIOPOL
Biopol Chemicals Limited
49 cr4.1x0.9x-23.3%0.3312.0%-0.00%

Swipe the table sideways for more columns. Tap a heading to sort. A dash means the figure is not filed or cannot be worked out for that company. A bigger cohort is cut to its 40 largest companies.

Monthly price changeThe share's price change in every calendar month, one row per year, so you can check for yourself whether a month has a pattern.

Month by month
YearJanFebMarAprMayJunJulAugSepOctNovDecYear
2026
·
·
+1.5
+20.4
-8.9
-11.3
+7.9
-49.7
+5.4
-13.9
-2.9
·
-52.8%
9m
Monthly movebelow -10%-10 to -5-5 to -2-2 to 00 to +2+2 to +5+5 to +10above +10%month in progress

Month-on-month change in closing price, adjusted for splits and bonuses but not for dividends, so a large dividend shows up here as a fall. Starts from 1995, when the exchange began trading equities, or from the stock's listing if later. This is a record of what happened, not a forecast.

Deals and filingsLarge trades reported to the exchange, plus the company's documents sorted by type.

DatePartySideQuantityPriceValue
2026-09-03NEO APEX SHARE BROKING SERVICES LLP · bulkSELL70,800₹41.38₹0.29 Cr
2026-09-03NEO APEX SHARE BROKING SERVICES LLP · bulkBUY33,600₹39.64₹0.13 Cr
2026-09-02NEO APEX SHARE BROKING SERVICES LLP · bulkSELL57,600₹41.55₹0.24 Cr
2026-09-01NEO APEX SHARE BROKING SERVICES LLP · bulkBUY94,800₹46.15₹0.44 Cr
2026-08-31MANSI SHARE AND STOCK BROKING PRIVATE LIMITED · bulkBUY88,800₹51.28₹0.46 Cr
2026-08-31MANSI SHARE AND STOCK BROKING PRIVATE LIMITED · bulkSELL66,000₹51.36₹0.34 Cr
2026-08-24CRAFT EMERGING MARKET FUND PCC-CITADEL CAPITAL FUND · bulkSELL1,20,000₹98.90₹1.19 Cr
2026-08-21BEACON STONE CAPITAL VCC - BEACON STONE I · bulkSELL1,18,800₹99.89₹1.19 Cr

Read enough? Test BIOPOL. “Buy BIOPOL when RSI(14) drops below 30, sell at 10% profit or after 20 days.” Real prices, every charge counted.

Run it free